Clinical Trial Update: The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Dimephosphon for acute ischemic stroke, currently recruiting to evaluate efficacy and safety. Sponsor is Tatchempharmpreparaty, JSC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Dimephosphon (dimephosphon)

Snippet

Sponsor: Tatchempharmpreparaty, JSC | Conditions: Stroke, Acute Stroke | Phase 3 | Status: RECRUITING